Economic Innovation
Awards

Research to results: Q&A with Ravini Moodley on scaling innovation in a constrained economy

From blombos to beyond: Celebrating South Africa’s zany DNA of innovation

Jacques Moolman

All systems go for this year's WC Economic Innovation Awards at the CT City Hall

MADE POSSIBLE BY:

More 2026 Western Cape Economic Innovation Awards

Subscribe & Follow

Advertise your job vacancies

Cipla and Teva extend supply and distribution chain in SA

3 Oct 2016

The Competition Commission has approved an agreement between Teva Pharmaceutical Industries and Cipla Medpro for the former's newly acquired Allergan Generic business (Actavis Pharma and Pharmascript) to be incorporated in the existing Cipla-Teva supply and distribution chain in South Africa.

Under this partnership, Cipla Medpro will market Actavis’ product portfolio, inclusive of products in the MCC pipeline.

Cipla and Teva extend supply and distribution chain in SA

The partnership leverages the commercial strength of Cipla Medpro in South Africa together with the strong global product pipeline of Teva. It spans across a number of therapeutic areas such as oncology, cardiovascular, CNS, and over-the-counter products.

Paul Miller, CEO of Cipla sub-Saharan Africa, says:“We are very pleased with the addition of these new products, including strong brands like Accurate, Lokit, Amoclan and Sudocrem. Cipla’s strategy is to grow through such alliances. Ultimately, patients benefit with better reach of quality medicines.”

Erez Israeli, president and CEO of Teva growth markets, notes that: “The partnership with Cipla Medpro SA allows us to reach millions of patients in South Africa, providing them with increased access to healthcare.”